Skip to main content
Clinical Trials/NCT04206748
NCT04206748
Recruiting
Not Applicable

iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes: a Pilot Randomized, Controlled Trial

The University of Texas Health Science Center, Houston1 site in 1 country200 target enrollmentNovember 12, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gestational Diabetes
Sponsor
The University of Texas Health Science Center, Houston
Enrollment
200
Locations
1
Primary Endpoint
Neonatal morbidity
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to investigate whether automation of glucose monitoring data to facilitate the total number of recommended and completed SMBG checks improve clinical outcomes for women living with gestational and type 2 diabetes during pregnancy? This is a RCT

Registry
clinicaltrials.gov
Start Date
November 12, 2019
End Date
November 1, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Joycelyn Ashby Cornthwaite

Assistant Professor

The University of Texas Health Science Center, Houston

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Neonatal morbidity

Time Frame: at the time of discharge (about 2-7 days after birth)

Neonatal intensive care unit (NICU) length of stay

Time Frame: delivery to discharge (2-7 days)

# of neonates who where Small for gestational age (SGA)

Time Frame: at delivery

Neonatal gestational age at delivery

Time Frame: at delivery

# of Neonates with hyperbilirubinemia-requiring therapy.

Time Frame: delivery to discharge (2-7 days)

Secondary Outcomes

  • Maternal Mean post prandial glucose(perinatal to postpartum (32 weeks))
  • Average Neonatal Weight(at the time of discharge (about 2-7 days after birth))
  • Maternal # of Hypoglycemia events (<60 mg/dl)(perinatal to postpartum (32 weeks))
  • Maternal weight gain during pregnancy(perinatal to postpartum (32 weeks))
  • Maternal Preeclampsia(perinatal to postpartum (32 weeks))
  • Maternal Mean fasting glucose(perinatal to postpartum (32 weeks))
  • Maternal Cesarean delivery(at delivery)
  • Effect of SMBG checks on pregnancy(perinatal to postpartum (32 weeks))
  • Maternal Gestational hypertension(perinatal to postpartum (32 weeks))
  • Maternal Operative vaginal delivery(at delivery)

Study Sites (1)

Loading locations...

Similar Trials